home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 15, 2019
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 528 active entries

Manus Aktteva Biopharma LLP

303, 3rd floor, Royale Manor, Lawgarden,
380006
India
Toll free: +919879167919, +91 9979866376

Phone: +91 79 26463394
Fax: +91-79-26463395

Description:

J-INC, now known as Manus Aktteva is successfully representing manufacturers from INDIA, and manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & Middle-east, for supply of commercial quantities, pilot lots, & for R&D Purposes. We can fulfill your requirements of Nutraceuticals, Pharmaceutical API’s, advance level intermediates, from manufacturers, who comply with ISO Certification, GMP, CGMP, USFDA approved units with supportive regulatory documentations like DMF open part, DMF in CTD format, EDMF, COS, CEP no, USDMF etc.
While the list of the currently hot products of the Pharma Industry facilitated by J.INC, website www.j-inc.biz ,

We wish to state that anyone interested in sourcing any special molecules, API’s, Intermediates, Chiral compounds, Carbohydrate Molecules, Phytochemicals, Herbal Extracts, Alkaloids, Nutraceuticals, etc. and feels it is difficult for early completion of tasks, please call on us and TEST US TO GET THE BEST OF US. Pleasure will be ours to serve you PROMPTLY, EFFICIENTLY and COMPETITIVELY.

 

DISCLAIMER :

  • While all due diligence possible will be done and we will cooperate on all matters if any problem arises during course of sourcing , we cannot be held responsible for any non compliance or complications in transaction that may happen, which is beyond our control.
  • Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.

 

PATENTS

ü  Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

ü  Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)

ü  Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Manus Aktteva Biopharma LLP makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.

ü  Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.

ü  Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual.

The range of Nutraceutical Rawmaterials, Pellets, APIS & Pharma Intermediates offered by us are as follows:

 

Almotriptan,181183-52-8,

Eletriptan hydrobromide,177834-92-3,

Frovatriptan succinate hydrate,158930-17-7,

Naratriptan hydrochloride,143388-64-1,

Rizatriptan benzoate,145202-66-0,

Sumatriptan succinate,103628-48-4,

Zolmitriptan,139264-17-8,

Pramipexole,104632-26-0,

N-Acetyl-L-hydroxyproline,33996-33-7,

Sertraline hydrochloride,79559-97-0,

Brimonidine D-tartrate,70359-46-5,

Sumatriptan,103628-46-2,

3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol hydrochloride,175591-09-0,

Almotriptan,154323-57-6,

N-[(4-Aminophenyl)-methylsulfonyl]pyryolidine,334981-10-1,

N-[(4-Nitrophenyl)-methylsulfonyl]pyryolidine,340041-91-0,

Eletriptan,143322-58-1,

4-(Methylamino)cyclohexanone 2,2-dimethyltrimethylene ketal hydrochloride,158747-10-5,

Naratriptan,121679-13-8,

N-Methyl-1H-indole-5-ethanesulfonamide,98623-50-8,

Rizatriptan,144034-80-0,

4-(1H-1,2,4-Triazol-1-ylmethyl)aniline,119192-10-8,

N-(4-methoxy-2-methylquinolin-6-yl)acetamide,100795-23-1,

4,6-Diamino-2-Methyl-Quinoline,5443-31-2,

Pramipexole dihydrochloride,104632-25-9,

(S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine,106092-09-5,

2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole,104617-49-4,

 6-Acetamido-2-amino-4,5,6,7-tetrahydrobenzothiazole,104617-51-8,

N-(4-Oxocyclohexyl)acetamide,27514-08-5,

trans-4-Acetamidocyclohexanol,23363-88-4,

4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidinyl-5-yl-formyl,147118-37-4,

[[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]methyl]triphenylphosphonium bromide,885477-83-8,

Linezolid,165800-03-3,

(R)-5-(Azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone,168828-84-0,

(R)-[3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl methanesulfonate,174649-09-3,

(5R)-3-(3-Fluoro-4-(4-morpholinyl)phenyl)-5-hydroxymethyl-2-oxazolidione,168828-82-8,

3-Fluoro-4-morpholinoaniline,93246-53-8,

4-(2-Fluoro-4-nitrophenyl)morpholine,2689-39-6,

6-Aminoquinoxaline,6298-37-9,

5-Bromoquinoxalin-6-amine,50358-63-9,

Dronedarone hydrochloride,141625-93-6,

(2-Butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone,141627-42-1,

(2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone,141645-16-1,

(2-Butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone,141645-23-0,

(5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone oxalate,851014-95-4,

7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one,160129-45-3,

3-(4-Chloro-1-oxobutyl)-1H-indole-5-carbonitrile,276863-95-7,

3-(4-Chlorobutyl)indole-5-carbonitrile,143612-79-7,

Ethyl 5-nitrobenzofuran-2-carboxylate,69604-00-8,

Ethyl 5-amino-1-benzofuran-2-carboxylate,174775-48-5,

5-(1-Piperazinyl)-2-benzofurancarboxylic acid ethyl ester hydrochloride,765935-67-9,

Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate,163521-20-8,

5-(1-Piperazinyl)benzofuran-2-carboxamide,183288-46-2,

1-Aminoindane hydrochloride,70146-15-5,

(R)-(-)-1-Aminoindane hydrochloride,10305-73-4,

3-({2-[(4-Cyano-phenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic acid ethyl ester,211915-84-5,

3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester,212322-56-0,

Ethyl 3-(pyridin-2-ylamino)propanoate,103041-38-9,

N-(4-Cyanophenyl)glycine,42288-26-6,

4-Methylamino-3-nitrobenzoic acid,41263-74-5,

2-Bromo-6-nitrophenol,13073-25-1,

1-Bromo-2-methoxy-3-nitrobenzene,98775-19-0,

3-Bromo-2-methoxyaniline,116557-46-1,

3,5-Bis(2-cyanoprop-2-yl)toluene,120511-72-0,

Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate,161797-99-5,

Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate,161798-01-2,

Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate,161798-03-4,

Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate,160844-75-7,

Hexafluoropropylene,116-15-4,

Acenocoumarol,152-72-7,

Amlodipine besylate ,111470-99-6,

Amphotericin B,1397-89-3,

Azithromycin dihydrate,117772-70-0,

Azithromycin,83905-01-5,

Chloramphenicol,56-75-7,

Chloramphenicol palmitate,530-43-8,

Clarithromycin,81103-11-9,

Empagliflozin,864070-44-0,

Erythromycin,114-07-8,

Erythromycin estolate,3521-62-8,

Erythromycin ethylsuccinate,1264-62-6,

Erythromycin-9-oxime,13127-18-9,

Erythromycin phosphate,4501-00-2,

Erythromycin stearate,643-22-1,

Fluticasone furoate,397864-44-7,

Fluticasone propionate,80474-14-2,

Oxytetracycline,79-57-2,

Oxytetracycline hydrochloride,2058-46-0,

Palonosetron hydrochloride,135729-62-3,

Phenylbutazone,50-33-9,

Rosuvastatin calcium,147098-20-2,

Roxithromycin,80214-83-1,

Sevelamer carbonate,845273-93-0,

Sevelamer hydrochloride,152751-57-0,

Sildenafil citrate,171599-83-0,

Cialis,171596-29-5,

Tetracycline hydrochloride,64-75-5,

Tiapride,51012-32-9,

Vardenafil hydrochloride trihydrate,330808-88-3,

Calcitriol,32222-06-3,



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Pharmaceutical
- Research
Supplier
- Distributor
- Research
Consulting
- Research
Contract
- Research

Last update of this entry: October 16, 2019

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.